B oth hydrocephalus and cerebral palsy are often associated with a number of comorbid conditions, such as spina bifida and spinal deformity. 15, 17 The most notable of these deformities is scoliosis, a condition that is characterized by a > 10° lateral curvature of the spine.
ship between spinal fusion and increased implant failure in patients with preexisting implants. 1, 4, 6, 7, [9] [10] [11] [12] 15, 18 Common causes of implant failures include infection, malfunction, obstruction, and catheter fracture. 2, 16 A number of hypotheses have been proposed to explain a relationship with spinal fusion; for example, causes of shunt failure have been hypothesized to include newly introduced mechanical stress, growth-related stress, and surgical technique. 15 Previous publications in this area have primarily been case reports, hypothesizing the potentially increased risk of neurosurgical implant complications after spinal fusion surgery. Few large studies have quantitatively analyzed the association between scoliosis fusion and failure of preexisting neurosurgical implants. Therefore, we sought to use retrospective analysis to 1) investigate the rate of implant complications related to scoliosis fusion, 2) analyze causes of implant complications, and 3) find factors that place patients at higher risk for implant-related complications.
Methods
A total of 75 pediatric patients with neuromuscular scoliosis who underwent fusions between August 2005 and August 2016 at Monroe Carell Jr. Children's Hospital were retrospectively selected from available billing information and chart review. Inclusion criteria selected for patients who 1) received surgical treatment (posterior arthrodesis/posterior segmental instrumentation) for scoliosis at Vanderbilt University Medical Center (VUMC), 2) had a minimum of 6 months of follow-up care at VUMC, and 3) had received an implant prior to their scoliosis fusion.
Data collected for each patient included patient demographics, implant history (prior to scoliosis fusion), spinal fusion information, and postoperative follow-up. Patient demographics included date of birth, sex, race, ethnicity, and insurance status. Implant history encompassed the type and side of the implant(s), the date of the most recent implant procedure, and the type of operation. Information regarding the spinal fusion included the date of the surgery, vertebral levels fused, side of the major Cobb angle, pre-and postoperative Cobb angle measurements, and postoperative complications (including details of postoperative spine wound complications/infections). All Cobb angles were measured using upright spinal radiographs at the most recent date prior to fusion (preoperative) and the earliest date following fusion (postoperative). Finally, follow-up information included any returns to the operating room (OR) within 180 days, the indication for the return to the OR, and information about the patient's next neurosurgical operation (if applicable).
Results
Overall, 793 posterior spinal fusions were performed at Monroe Carell Junior Children's Hospital from August 2005 to August 2016. Of these, 75 (9.5%) were performed on patients with preexisting baclofen pumps and/or ventricular shunts. Demographics for this cohort are shown in Table 1 .
Of the 75 included patients, 31 had solely a ventricular shunt (VS), 39 had solely an intrathecal baclofen pump (BP), and 5 had both. In total, 69/75 (92.0%) had their most recent implant surgery prior to scoliosis correction performed at our institution. Table 2 reports information regarding the implant characteristics for both VSs and BPs. In all, there were 36 VSs, almost all of which were ventriculoperitoneal shunts (97.2%), and there were 44 BPs. For both VSs and BPs, a majority of implants were placed on the patient's right side. There were more VSs placed on the concave side of the patient's scoliosis curvature, whereas BPs were more commonly placed on the convex side.
The indications for implant placement are shown in Table 3 . For VS placement, the most common indications were spina bifida, congenital hydrocephalus, intraventricular hemorrhage, trauma, and infection. A large majority (90.9%) of the BPs were placed due to nontraumatic cerebral palsy.
Information about each patient's most recent implant operation (prior to spinal fusion) is provided in Table 4 . For a majority of VSs, there was a revision following initial placement of the shunt. On the other hand, a majority of BPs did not require revision. Patients were followed routinely by neurosurgery for VS and BP care. No additional implant-related follow-up was provided prior to or after the spine fusion.
A summary of characteristics related to the spinal fusion procedures is provided in Table 5 . The patients' mean age at spinal fusion was 13.49 ± 2.78 years (range 3.62-18.81 years), and the fusion procedure was performed an average of 5.70 years (SD 4.65 years, range 0.10-17.3 years) after their most recent implant operation. The mean preoperative and postoperative Cobb angles were 62.4° ± 18.9° (range 20.9°-109.0°) and 23.5° ± 13.3° (range 2.00°-67.3°), respectively, resulting in an average Cobb angle change of 38.92°. The average number of vertebral levels fused was 14.20. In all cases, patients had both thoracic and lumbar vertebrae fused. Ten patients (13.3%) required postoperative irrigation and debridement (I&D) of their spinal wound; however, no implants needed to be removed, and no I&D of cranial or abdominal wounds was required. Of note, spine fusion cases follow a standard surgical-site infection reduction protocol at our institution, and these cases are tracked.
A list of patients requiring I&D following posterior spinal fusion is provided in Table 6 . Of these, 7 patients had VSs and 3 had BPs, and half of the cases included subfascial involvement. Of note, in 2 cases, the BP catheter was seen during the I&D; however, neither patient required revision, removal, or replacement of the pump. In one of these 2 cases, cultures were positive for coagulase-negative Staphylococcus, and in the other they demonstrated methicillin-resistant S. aureus. The patient in the first of these 2 cases was treated with 2 I&D procedures, 8 weeks of intravenous (IV) vancomycin and rifampin, followed by 6 months of oral trimethoprim/sulfamethoxazole and rifampin. The second patient required 3 I&D procedures, 8 weeks of IV vancomycin, and 8 months of oral levofloxacin and rifampin. All 7 patients were initially treated with a course of IV antibiotics and then transitioned to longerterm oral antibiotics. After discharge, they were followed in both spine and infectious disease outpatient clinics. Table 7 shows all follow-up implant operations that were performed within 180 days of spinal fusion. No patient had VS complications and 2 patients had BP complications related to spinal fusion (unintended BP catheter cutting during posterior spinal fusion, which required intraoperative repair, in both cases). In each of these cases, the BP catheter was violated during exposure of the spine. When the complication was identified, a new catheter was inserted into the intrathecal space and connected to the end of the previous catheter leading to the generator. The fusion operation was then continued to completion. Four other pump operations were planned (catheter repositioning or pump replacement for end of generator life) and are not considered complications of the spinal fusion. There were no cases of baclofen withdrawal, baclofen overdose, CSF leak, or cranial or abdominal wound revisions.
Discussion
Patients who receive neurosurgical implants, including VSs and BPs, often have a number of comorbid conditions. One of the most common of these conditions is scoliosis, which may occur due to a variety of factors in many patients with spina bifida or cerebral palsy. 1, 15 In turn, such patients often are treated with spinal fusion to aid in scoliosis correction.
Prior studies have presented evidence of an increase in neurosurgical implant failure rates following neuromuscular scoliosis correction. For example, Caird et al. provided evidence that spinal fusion increases the rate of BP failure, and Lai et al. provided a series of cases pertaining to shunt failure. 7, 15 More recently, Hatano et al. reported a 21% shunt complication rate following spinal fusion.
11 A number of hypotheses have been proposed for this relationship; these include mechanical stress, aged or brittle implants, and surgical technique. 15 However, prior evidence has not been consistent; both Borowski et al. and Yaszay et al. found that posterior spinal fusion did not increase complication rates in baclofen pumps. 6, 18 In the present study, 6 of the 75 included patients required some form of implant revision within 180 days of their spinal fusion. Only 2 of these revisions were considered to be potential spinal fusion complications, as 3 patients needed baclofen pump revisions due to battery end-of-life, and 1 patient had an intraoperative revision that was planned prior to scoliosis correction. Our study indicates that implant failure rates are not significantly higher following spinal fusion. However, increased care, especially during the exposure portion of the procedure, must be undertaken. Due to the low failure rate in our study, potential underlying causes of implant failure (such as time between surgeries, age at fusion, number of levels fused, and Cobb angle change) could not be analyzed.
There are a number of reasons why the failure rate following spinal fusion may not be higher than the general implant failure rate. It could be that changes to the integrity of the implant or newly placed mechanical stress are simply not notable enough to cause functional failure of the device. Additionally, it may be that the surgical technique regarding implant placement is accommodating of future spinal fusion, such as through the placement of excess shunt tubing. It is important to note that although the overall rate of VS failure is decreasing compared to historical controls, there remains a baseline rate of failure in the natural history of VS in the overall population.
14 Although we did not observe VS failure in the 36 patients with VSs, it is likely this is due to the small size of our overall cohort.
One important statistic to note is that the patients in this study had a large number of wound complications following spinal fusion. Specifically, 10 patients (13.3%) required at least 1 I&D procedure, which is consistent with the range of 5%-20% reported for infection rates in neuromuscular scoliosis fusions in the literature. 8 In our 10 cases, half of the infections were suprafascial only. In two of the cases in which I&D was required, BP pump catheters were seen in the field. The catheters were left in place, and fortunately, no subsequent removal or revision was required. All patients who required I&D received an initial course of IV antibiotics, and transitioned to longerterm oral antibiotics.
It is also important to note that many surgeons intentionally cut the BP catheter in the initial stages of the scoliosis correction operation and reconnect it at the end of the case. However, this is not the standard practice at our institution, due to concern over baclofen withdrawal or lack of baclofen relief in the initial postoperative period due to interruption of baclofen infusion during the surgery. We suggest that the pump tubing be left intact during the spine surgery if possible. This study is not without limitations, the most notable of which being the sample size. In this study, there were only 2 patients who were deemed to have an unexpected implant failure within 180 days of spinal fusion. Given that 2 cases were identified in our study cohort of 75 patients, assuming a case-control study design and power of 0.80, we would need over 3500 controls to properly assess the impact of spinal fusion on implant failure. It is difficult to find a large number of similar patients at any one institution; accordingly, a large, multicenter study including high-volume institutions, would be needed to convincingly determine the impact of spinal fusion on implant failure.
Conclusions
In conclusion, our study suggests that patients with previously placed neurosurgical implants are not at increased risk for implant failure following spinal fusion for scoliosis correction. While additional surgical caution must be used to avoid damage to the implant structure and functional integrity, spinal fusions can still be performed safely in this group of patients. Further large-scale, multicenter studies should be performed to validate this finding.
